SBIR-STTR Award

Rnai Cancer Therapeutics Using Nanotechnology; Hhsn2612013000
Award last edited on: 1/26/16

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$200,000
Award Phase
1
Solicitation Topic Code
NCI
Principal Investigator
Gretchen M Unger

Company Information

GeneSegues Inc

10285 Yellow Circle Drive
Minnetonka, MN 55343
   (612) 354-5753
   lb@genesegues.com
   www.genesegues.com
Location: Single
Congr. District: 03
County: Hennepin

Phase I

Contract Number: N43CA130030
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2013
Phase I Amount
$200,000
The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer. PUBLIC HEALTH RELEVANCE

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----